Author:
Reichow Brian,Volkmar Fred R.,Bloch Michael H.
Publisher
Springer Science and Business Media LLC
Subject
Developmental and Educational Psychology
Reference41 articles.
1. Aman, M. G., Arnold, L., McDougle, C. J., Vitiello, B., Scahill, L., Davies, M., et al. (2005). Acute and long-term safety and tolerability of risperidone in children with autism. Journal of Child and Adolescent Psychopharmacology, 15(6), 869–884.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual (4th ed., text revision). Washington, DC: American Psychiatric Association.
3. Arnold, L. E., Aman, M. G., Cook, A. M., Witwer, A. N., Hall, K. L., Thompson, S., et al. (2006). Atomoxetine for hyperactivity in autism spectrum disorders: Placebo-controlled crossover pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry, 45(10), 1196–1205.
4. Borenstein, M., Hedges, L., Higgins, J., & Rothstein, H. (2005). Comprehensive meta-analysis 2. Englewood, NJ: Biostat.
5. Cheng, J. Y. W., Chen, R. Y. L., Ko, J. S. N., & Ng, E. M. L. (2007). Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—meta-analytsis and meta-regression analysis. Pyschopharmacology, 194(2), 197–209.
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献